Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,900 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sensitivity assessment of diphacinone by pharmacokinetic analysis in invasive black rats in the Bonin (Ogasawara) Archipelago, Japan.
Takeda K, Shimizu K, Sato M, Katayama M, Nakayama SMM, Tanaka K, Ikenaka Y, Hashimoto T, Minato R, Oyamada Y, Tanaka KD, Kimura G, Tanikawa T, Kato K, Kusakabe T, Ishizuka M, Kamata R. Takeda K, et al. Among authors: hashimoto t. Pestic Biochem Physiol. 2024 Feb;199:105767. doi: 10.1016/j.pestbp.2023.105767. Epub 2024 Jan 1. Pestic Biochem Physiol. 2024. PMID: 38458676
Toxicokinetic analysis of the anticoagulant rodenticides warfarin & diphacinone in Egyptian fruit bats (Rousettus aegyptiacus) as a comparative sensitivity assessment for Bonin fruit bats (Pteropus pselaphon).
Takeda K, Manago K, Morita A, Kawai YK, Yasuo N, Sekijima M, Ikenaka Y, Hashimoto T, Minato R, Oyamada Y, Horikoshi K, Suzuki H, Ishizuka M, Nakayama SMM. Takeda K, et al. Among authors: hashimoto t. Ecotoxicol Environ Saf. 2022 Sep 15;243:113971. doi: 10.1016/j.ecoenv.2022.113971. Epub 2022 Aug 15. Ecotoxicol Environ Saf. 2022. PMID: 35981482 Free article.
C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma.
Uchimoto T, Matsuda T, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Hashimoto M, Higashio T, Tsuchida S, Nishimura K, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Miki J, Fujita K, Kimura T, Ohno Y, Shiroki R, Uemura H, Azuma H. Uchimoto T, et al. Among authors: hashimoto t. Target Oncol. 2024 May 28. doi: 10.1007/s11523-024-01068-7. Online ahead of print. Target Oncol. 2024. PMID: 38807017
The Beni-Koji scandal and Japan's unique health food system.
Hashimoto T, Ozaki A, Hakariya H, Takahashi K, Tanimoto T. Hashimoto T, et al. Lancet. 2024 May 25;403(10441):2287-2288. doi: 10.1016/S0140-6736(24)00882-1. Lancet. 2024. PMID: 38796200 No abstract available.
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.
RECAP study group; Tsukamoto S, Kobayashi K, Toyoda M, Tone A, Kawanami D, Suzuki D, Tsuriya D, Machimura H, Shimura H, Wakui H, Takeda H, Yokomizo H, Takeshita K, Chin K, Kanasaki K, Miyauchi M, Saburi M, Morita M, Yomota M, Kimura M, Hatori N, Nakajima S, Ito S, Murata T, Matsushita T, Furuki T, Hashimoto T, Umezono T, Muta Y, Takashi Y, Tamura K. RECAP study group, et al. Among authors: hashimoto t. Diabetes Obes Metab. 2024 May 19. doi: 10.1111/dom.15652. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38764356
6,900 results